EyePoint Pharmaceuticals, Inc. — Director's Dealing 2019

Apr 2, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: EyePoint Pharmaceuticals, Inc. (EYPT)
CIK: 0001314102
Period of Report: 2019-04-01

Reporting Person: Ross Leonard S (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-04-01	Common Stock	M	5000.00	$1.81	Acquired	79452.00	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-04-01	Stock Option (Right to Buy)	$1.81	M	5000.00	Disposed	2019-06-25	Common Stock (5000.00)	Direct

Footnotes

F1: The option was granted on 6/25/2009 and vested in four equal annual installments beginning on the first anniversary of the grant.